Product Center
Han Liming, the then Secretary of the Taizhou Municipal Party Committee, went to the company for an investigation.
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2018-04-24
- Views:
(Summary description)Han Liming, the then Secretary of the Taizhou Municipal Party Committee, went to the company for an investigation.
Han Liming, the then Secretary of the Taizhou Municipal Party Committee, went to the company for an investigation.
(Summary description)Han Liming, the then Secretary of the Taizhou Municipal Party Committee, went to the company for an investigation.
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2018-04-24 10:57
- Views:
Information

Scan the QR code to read on your phone
Relevant information
-
The world's first! The monkeypox mRNA vaccine has obtained dual clinical trial approvals from both China and the United States.
Recently, the IND application for a Class 1 new drug, the "Monkeypox mRNA vaccine," jointly submitted by Ab&B Bio-Tech CO.,LTD.JS (Ab&B Bio) and its subsidiary Yither Biotech CO., Ltd (Yither Bio), was approved by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration. - Phase I/II Clinical Trial of the Re engineered Respiratory Syncytial Virus Vaccine (CHO Cells)(Adjuvant)Officially Launched 05-13
- The mRNA technology platform has achieved another milestone, with global innovation efforts accelerating. 05-08
- Our innovative vaccine research team won the 20th "Jiangsu Youth May Fourth Medal Collective" award 04-27
- The Ab&B Bio Promotion Business Conference and 10th Anniversary Celebration were successfully held 04-25
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us